$3.77
+0.07(1.89%)
Mkt Cap $711M
$1.21
$6.45
52-Week Range
At A Glance
1
Atai Beckley NV is a clinical-stage biopharmaceutical company.
2
Revenue is primarily driven by Reportable Segment Aggregation Before Other Operating Segment (100%).
3
No significant events in the past 90 days.
$711M
Market Cap
$2M
Revenue
-$396M
Net Income
Employees54
Fundamentals
How The Business Makes Money
Revenue by Segment
Reportable Segment Aggregation Before Other Operating Segment100%($622.0K)
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIK0001840904
ISINUS04650F1012
CUSIPN0731H103
Phone31 20 793 2536
AddressProf. J.H. Bavincklaan 7, Amstelveen, 1183 AT, NL
SEC EDGAR